Brenda Libby Coleman

Array ( [id] => 8317492 [patent_doc_number] => 08232270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-31 [patent_title] => 'Bivalent (−)-meptazinol compounds and/or their salts, and their preparation and futilization' [patent_app_type] => utility [patent_app_number] => 12/309580 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4458 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12309580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085922 [patent_doc_number] => 20070275973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'ARYL FUSED AZAPOLYCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/778890 [patent_app_country] => US [patent_app_date] => 2007-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28832 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275973.pdf [firstpage_image] =>[orig_patent_app_number] => 11778890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380304 [patent_doc_number] => 20090192143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Substituted diazepan orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/309239 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15368 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192143.pdf [firstpage_image] =>[orig_patent_app_number] => 12309239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404529 [patent_doc_number] => 20090239843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Bridged diazepan orexin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/309243 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16905 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239843.pdf [firstpage_image] =>[orig_patent_app_number] => 12309243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6355620 [patent_doc_number] => 20100022490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Zilpaterol Enantiomer Compositions and Methods of Making and Using Such Compositions' [patent_app_type] => utility [patent_app_number] => 12/373221 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13275 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022490.pdf [firstpage_image] =>[orig_patent_app_number] => 12373221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374807 [patent_doc_number] => 20100075955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'SHORT-ACTING BENZODIAZEPINE SALTS AND THEIR POLYMORPHIC FORMS' [patent_app_type] => utility [patent_app_number] => 12/373457 [patent_app_country] => US [patent_app_date] => 2007-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6851 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075955.pdf [firstpage_image] =>[orig_patent_app_number] => 12373457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570525 [patent_doc_number] => 20090253904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Process for the Preparation of a Tetrahydro-1H-Azepines' [patent_app_type] => utility [patent_app_number] => 12/373936 [patent_app_country] => US [patent_app_date] => 2007-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2393 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253904.pdf [firstpage_image] =>[orig_patent_app_number] => 12373936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5029038 [patent_doc_number] => 20070270485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'Byrostatin analogues, synthetic methods and uses' [patent_app_type] => utility [patent_app_number] => 11/825092 [patent_app_country] => US [patent_app_date] => 2007-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60111 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270485.pdf [firstpage_image] =>[orig_patent_app_number] => 11825092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4933490 [patent_doc_number] => 20080004265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'HIV Integrase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/768458 [patent_app_country] => US [patent_app_date] => 2007-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38063 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20080004265.pdf [firstpage_image] =>[orig_patent_app_number] => 11768458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199740 [patent_doc_number] => 20070299058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Anxiolytic Agents With Reduced Sedative And Ataxic Effects' [patent_app_type] => utility [patent_app_number] => 11/767515 [patent_app_country] => US [patent_app_date] => 2007-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26917 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299058.pdf [firstpage_image] =>[orig_patent_app_number] => 11767515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670447 [patent_doc_number] => 20080045507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'SUBSTITUTED BENZAMIDE MODULATORS OF THE HISTAMINE H3 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/766144 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17391 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045507.pdf [firstpage_image] =>[orig_patent_app_number] => 11766144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670448 [patent_doc_number] => 20080045508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'SUBSTITUTED AMINOMETHYL BENZAMIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/766153 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17675 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045508.pdf [firstpage_image] =>[orig_patent_app_number] => 11766153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5350005 [patent_doc_number] => 20090005366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'DEUTERIUM-ENRICHED OLANZAPINE' [patent_app_type] => utility [patent_app_number] => 11/765432 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3713 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005366.pdf [firstpage_image] =>[orig_patent_app_number] => 11765432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316488 [patent_doc_number] => 20090281086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => '2 -OXYHETEROARYLAMIDE DERIVATIVES AS PARP INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/304835 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15964 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281086.pdf [firstpage_image] =>[orig_patent_app_number] => 12304835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265810 [patent_doc_number] => 20090118495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Process for the Preparation of 6-alpha,9-alpha-difluoro-17-alpha-((2-furanylcarbonyl)oxy)-11-beta-hydroxy-16-alpha-methyl-3-oxo-androsta-1,4-diene-17-beta- -carbothioic acid S-fluoromethyl' [patent_app_type] => utility [patent_app_number] => 12/304839 [patent_app_country] => US [patent_app_date] => 2007-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2686 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118495.pdf [firstpage_image] =>[orig_patent_app_number] => 12304839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231367 [patent_doc_number] => 20070293475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'ARYL AND HETEROARYL TETRAHYDROBENZAZEPINE DERIVATIVES AND THEIR USE FOR TREATING GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 11/761493 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7046 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293475.pdf [firstpage_image] =>[orig_patent_app_number] => 11761493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4567940 [patent_doc_number] => 07847094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Industrial preparation of 11-[4-{2-(2-hydroxyethoxy) ethyl}-1-piperazinyl] dibenzo [b,f]-[1,4]thiazepine' [patent_app_type] => utility [patent_app_number] => 11/808360 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2899 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/847/07847094.pdf [firstpage_image] =>[orig_patent_app_number] => 11808360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4460830 [patent_doc_number] => 07879826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them' [patent_app_type] => utility [patent_app_number] => 11/758459 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11289 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879826.pdf [firstpage_image] =>[orig_patent_app_number] => 11758459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4460822 [patent_doc_number] => 07879825 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/757006 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11727 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879825.pdf [firstpage_image] =>[orig_patent_app_number] => 11757006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 580326 [patent_doc_number] => 07452876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors' [patent_app_type] => utility [patent_app_number] => 11/756203 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11499 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452876.pdf [firstpage_image] =>[orig_patent_app_number] => 11756203 [rel_patent_id] =>[rel_patent_doc_number] =>)